[1]韦柳迎 文乐敏.糖尿病与肺结核共病的研究进展[J].大众科技,2023,25(8):124-127.
　Research Progress on Comorbidity of Diabetes and Pulmonary Tuberculosis[J].Popular Science & Technology,2023,25(8):124-127.
点击复制

糖尿病与肺结核共病的研究进展()
分享到：

《大众科技》[ISSN:1008-1151/CN:45-1235/N]

卷:
25
期数:
2023年8
页码:
124-127
栏目:
医药与卫生
出版日期:
2023-08-20

文章信息/Info

Title:
Research Progress on Comorbidity of Diabetes and Pulmonary Tuberculosis
作者:
韦柳迎1; 2 文乐敏1; 2　
（1.南宁市第四人民医院，广西 南宁 530023；2.广西艾滋病临床治疗中心（南宁），广西 南宁 530023）
关键词:
糖尿病; 肺结核; 共病
Keywords:
diabetes;  pulmonary tuberculosis;  comorbidity
文献标志码:
A
摘要:
研究发现，糖尿病和肺结核共病发生率高，病情复杂，且增加了临床糖尿病和肺结核护理的难度，两者间既相互影响，又互为危险因素。文章总结了共病的概念、糖尿病与肺结核共病的流行病学、相互作用、筛查以及管理方面的研究进展，旨在突出两者的相关性，为临床个体化诊断及治疗提供理论依据。
Abstract:
Studies found that diabetes and pulmonary tuberculosis have a high incidence of comorbidity and complicated condition, which increases the difficulty of clinical nursing for diabetes and pulmonary tuberculosis. Both of them affect each other and are risk factors for each other. This article reviews the concept of comorbidity, the epidemiology, interaction, screening and management of comorbidity between diabetes and tuberculosis, in order to highlight the correlation between them and provide theoretical basis for clinical individualized diagnosis and treatment.

参考文献/References:

[1]　汪敏，邝浩斌，袁园，等. 二甲双胍降糖治疗2型糖尿病合并肺结核的临床特点[J]. 实用医学杂志，2022，38(16): 2061-2065.[2] 汪清雅，胡代玉，张婷，等. 重庆市初治肺结核合并糖尿病患者的耐药情况分析[J]. 重庆医学，2021，50(2): 304-307，313.[3] NOUBIAP J J, NANSSEU J R, NYAGA U F, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and Meta-analysis of data from 2.3 million patients with tuberculosis[J]. Lancet Global Health, 2019, 7(4): e448-e460.[4] CACERES G, CALDERON R, UGARTE-GIL C. Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression[J]. Therapeutic Advances in Infectious Disease, 2022, 9: PMC9130847.[5] 姚叶萍，曾跃彬，邓永佳. 肺结核病合并2型糖尿病94例的临床特点分析[J]. 中国感染与化疗杂志，2021，21(3): 271-274.[6] 常峰，张冉，路云，等. 共病概念体系研究分析与设计[J]. 中国全科医学，2018，21(3): 256-260.[7] 李思思，张艳，李宏洁，等. 老年癌症患者共病的研究进展[J]. 中国全科医学，2020，23(7): 880-883，888.[8] 于普林. 老年医学[M]. 北京: 人民卫生出版社，2017.[9] MENESES K, BENZ R, AZUERO A, et al. Multimorbidity and Breast Cancer[J]. Seminars in Oncology Nursing. 2015, 31(2): 163-169.[10] VAN CREVEL R, KOESOEMADINATA R, HILL P C, et al. Clinical management of combined tuberculosis and diabetes[J]. International Journal of Tuberculosis and Lung Disease, 2018, 22(12): 1404-1410.[11] JEON C Y, MURRAY M B. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies[J]. PLOS Medicine, 2008, 5(7): e152.[12] RAHIM Z, MOMI M S, SAHA S K, et al. Pulmonary tuberculosis in patients with diabetes mellitus in Bangladesh[J]. International Journal of Tuberculosis and Lung Disease, 2012, 16(8): 1132-1133.[13] GOLDHABER-FIEBERT J D, JEON C Y, COHEN T, et al. Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants[J]. International Journal of Epidemiology, 2011, 40(2): 417-428.[14] 王胜难，郑亦慧，史琰琰，等. 上海市普陀区2012—2016年户籍人口糖尿病患者并发肺结核的情况及影响因素分析[J]. 复旦学报(医学版)，2021，48(1): 55-58.[15] 陈志飞，刘妍丽，连展. 糖尿病合并肺结核患者血糖控制水平与抗结核疗效的关系研究[J]. 中国医药导报，2019，16(26): 133-136.[16] LEE P H, LIN H C, HUANG A S, et al. Diabetes and risk of tuberculosis relapse: nationwide nested case-control study[J]. PLoS One. 2014, 9(3): e92623.[17] KAUR R, KAUR M, SINGH J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies[J]. Cardiovascular Diabetology, 2018, 17(1): 121.[18] YORKE E, ATIASE Y, AKPALU J, et al. The Bidirectional relationship between tuberculosis and diabetes[J]. Tuberculosis Research and Treatment, 2017, 2017: 1702578.[19] SALINDRI A D, WANG J, LIN H, et al. Post-tuberculosis incidence of diabetes, myocardial infarction, and stroke: Retrospective cohort analysis of patients formerly treated for tuberculosis in Taiwan, 2002-2013[J]. International Journal of Infectious Diseases. 2019, 84: 127-130.[20] 陆恩词，朱颖蔚. 肺结核合并糖尿病患者T淋巴细胞亚群及红细胞免疫功能的变化及意义[J]. 中国老年学杂志. 2017，37(3): 648-649.[21] FISHER-HOCH S P, WHITNEY E, MCCORMICK J B, et al. Type 2 diabetes and multidrug-resistant tuberculosis[J]. Scandinavian Journal of Infectious Diseases, 2008, 40(11-12): 888-893.[22] 柯玲，杨兰萍. 多学科团队协作延续护理对2型糖尿病合并肺结核患者生活质量的影响[J]. 基层医学论坛，2022，26(27): 48-50.[23] DOOLEY K E, CHAISSON R E. Tuberculosis and diabetes mellitus: Convergence of two epidemics[J]. Lancet Infectious Diseases, 2009, 9(12): 737-746.[24] BUASROUNG P, PETNAK T, LIWTANKIPIPAT P, et al. Prevalence of diabetes mellitus in patients with tuberculosis: A prospective cohort study[J]. International Journal of Infectious Diseases, 2022, 116: 374-379.[25] JIMENEZ-CORONA M E, CRUZ-HERVERT L P, GARCIA L, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes[J]. Thorax, 2013, 68(3): 214-220.[26] PEREZ-NAVARRO L M, RESTREPO B I, FUENTES- DOMINGUEZ F J, et al. The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes[J]. Tuberculosis, 2017, 103: 83-91.[27] HUANGFU P, UGARTE C, PEARSON F, et al. OP93?he effects of diabetes on tuberculosis treatment outcomes: An updated systematic review and Meta-analysis[J]. Journal of Epidemiology and Community Health, 2016, 70(Suppl 1): A50.[28] SALINDRI A D, KIPIANI M, KEMPKER R R, et al. Diabetes reduces the rate of sputum culture conversion in patients with newly diagnosed multidrug-resistant tuberculosis[J]. Open Forum Infectious Diseases, 2016, 3(3): w126.[29] 胡卫华，金龙，初乃惠. 耐多药/广泛耐药肺结核并发2型糖尿病患者耐药特征分析[J]. 中国防痨杂志，2021，43(1): 26-30.[30] 王志勇. 糖尿病合并肺结核患者的临床特征及其治疗效果[J]. 医疗装备，2018，31(6): 72-73.[31] RANZANI O T, RODRIGUES L C, BOMBARDA S, et al. Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in S? Paulo state, Brazil, 2010-2015: A population-based, longitudinal study[J]. Lancet Infectious Diseases, 2020, 20(1): 123-132.[32] World Health Organization. Collaborative framework for care and control of tuberculosis and diabetes[Z]. New York: World Health Organization, 2011.[33] HARREITER J, RODEN M. Diabetes mellitus-definition, classification, diagnosis, screening and prevention (update 2019)][J]. Wiener klinische Wochenschrift, 2019, 131(Suppl 1): 6-15.[34] 邓国防，周智广. 结核病与糖尿病共病的治疗管理专家共识[J]. 中国防痨杂志，2021，43(1): 12-22.[35] 杨铭，袁平，时正雨，等. 初治涂阳肺结核患者糖尿病患病率调查及其临床特点分析[J]. 现代临床医学，2022，48(2): 92-94， 106.[36] 曾剑锋，杨敏，唐芳，等. 糖尿病住院患者并发肺结核的临床特征分析[J]. 中国防痨杂志，2021，43(1): 31-35.[37] 张弦丽，秦道新，朱春园，等. 深圳市罗湖区社区2型糖尿病患者肺结核症状筛查结果分析[J]. 糖尿病天地，2021，18(9): 2-3.[38] 贝承丽，杨芬，傅满姣，等. 湖南省综合医院关于糖尿病患者中结核病筛查的问卷调查分析[J]. 中华结核和呼吸杂志，2022，45(9): 888-893.[39] QASEEM A, WILT T J, KANSAGARA D, et al. Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: A guidance statement update from the American College of Physicians[J]. Annals of Internal Medicine, 2018, 168(8): 569-576.[40] 汪敏，邝浩斌，袁园，等. 二甲双胍降糖治疗2型糖尿病合并肺结核的临床特点[J]. 实用医学杂志，2022，38(16): 2061-2065.[41] NOVITA B D. Metformin: A review of its potential as enhancer for anti tuberculosis efficacy in diabetes mellitus-tuberculosis coinfection patients[J]. Indian Journal of Tuberculosis, 2019, 66(2): 294-298.[42] DEGNER N R, WANG J Y, GOLUB J E, et al. Metformin use reverses the increased mortality associated with diabetes mellitus during tuberculosis treatment[J]. Clinical Infectious Diseases, 2018, 66(2): 198-205.[43] BERAN D, EWEN M, LAING R. Constraints and challenges in access to insulin: A global perspective[J]. Lancet Diabetes and Endocrinology, 2016, 4(3): 275-285.[44] 田瑶，刘辉敏，傅满姣，等. 结核病与糖尿病共病诊疗现状[J]. 结核与肺部疾病杂志，2022，3(2): 91-95.[45] GRANT P. Management of diabetes in resource-poor settings[J]. Clinical Medicine, 2013, 13(1): 27-31.[46] FAURHOLT-JEPSEN D, RANGE N, PRAYGOD G, et al. Diabetes is a strong predictor of mortality during tuberculosis treatment: A prospective cohort study among tuberculosis patients from Mwanza, Tanzania[J]. Tropical Medicine and International Health, 2013, 18(7): 822-829.[47] CHUNG W S, LIN C L, HUNG C T, et al. Tuberculosis increases the subsequent risk of acute coronary syndrome: A nationwide population-based cohort study[J]. International Journal of Tuberculosis and Lung Disease, 2014, 18(1): 79-83.[48] SHEU J J, CHIOU H Y, KANG J H, et al. Tuberculosis and the risk of ischemic stroke: A 3-year follow-up study[J]. Stroke, 2010, 41(2): 244-249.[49] HUAMAN M A, KRYSCIO R J, FICHTENBAUM C J, et al. Tuberculosis and risk of acute myocardial infarction: A propensity score-matched analysis[J]. Epidemiology and Infection, 2017, 145(7): 1363-1367.[50] 张燕娟，喻琰. 集束化护理干预在肺结核合并糖尿病患者中的应用效果[J]. 中国医药导报，2021，18(32): 167-170.[51] 李亚敏，高志东，陈曦，等. 移动互联网技术用于社区肺结核患者健康管理的接受意愿调查分析[J]. 中国防痨杂志，2020，42(12): 1313-1317.

相似文献/References:

[1]李赛花,黄萍.心理干预对糖尿病勃起功能障碍患者心理状态的影响[J].大众科技,2013,15(07):123.
[2]刘 毅.81 例糖尿病合并肺部感染临床分析[J].大众科技,2013,15(09):91.
[3]刘 丽.皮肤瘙痒症中糖尿病患者的调查研究[J].大众科技,2015,15(03):100.
　The investigation of diabetes in patients with pruritus[J].Popular Science & Technology,2015,15(8):100.
[4]吴植强 孔 妮.血糖仪检测技术进展综述[J].大众科技,2018,20(05):84.
[5]杨 雪 李俊良 李丽菊 杨晓宁 李聚林.血糖仪的临床应用与质量管理[J].大众科技,2022,24(08):108.
　Clinical Application and Quality Management of Blood Glucose Meter[J].Popular Science & Technology,2022,24(8):108.
[6]杨瑞春 林燕燕 潘素兰 潘仁丰 姚贤聪.穴位贴敷疗法治疗2 型糖尿病的临床研究进展[J].大众科技,2019,21(02):70.
　Clinical Research Progress of Acupoint Application Therapy in the Treatment of Type 2 Diabetes Mellitus[J].Popular Science & Technology,2019,21(8):70.
[7]周志鸿 韦燕飞 王 青 韩丝银 彭 岳 咸玉雪 彭金清 原鲜玲.蜂王浆抗糖尿病的研究进展[J].大众科技,2022,24(09):102.
　Research Progress in the Treatment of Diabetes with Royal Jelly[J].Popular Science & Technology,2022,24(8):102.
[8]杨 爽,杨颖珍,陈昶蓉.“一病一品”在糖尿病中医护理中的应用效果[J].大众科技,2019,21(06):108.
　Application Effect of “One Disease, One Quality” in TraditionalChinese Medicine Nursing for Diabetes[J].Popular Science & Technology,2019,21(8):108.
[9]马宁宁　陈莉娜　冼秋花.益气养阴汤加减治疗糖尿病理论浅析[J].大众科技,2020,22(12):54.
　A Brief Analysis on the Theory of Treating Diabetes by Yiqi Yangyin Decoction[J].Popular Science & Technology,2020,22(8):54.
[10]王昭文 周卓宁.TRPV1在防治糖尿病中的研究进展[J].大众科技,2021,23(12):79.
　Research Progress of TRPV1 in Prevention and Treatment of Diabetes Mellitus[J].Popular Science & Technology,2021,23(8):79.

备注/Memo

备注/Memo:
【收稿日期】2023-04-12【基金项目】南宁市科学研究与技术开发计划项目（No.20213025-3）。【作者简介】韦柳迎（1973－），女，南宁市第四人民医院副主任护师，研究方向为传染病护理与管理。【通信作者】文乐敏（1985－），男，南宁市第四人民医院副主任医师，研究方向为感染性疾病中医药防治研究。
更新日期/Last Update: 2023-08-24